Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14263, United States
Location status: Recruiting
NCT Number: NCT07182240
To assess the feasibility and provide information on the utility of noninvasive line field confocal optical coherence tomography (LC-OCT) for the presurgical assessment of Mohs micrographic surgery sites in patients undergoing removal of cutaneous basal cell carcinomas (BCC).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Buffalo, New York, 14263, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
handheld imaging device will take high resolution images of lesion
Time frame: 1.5 years
cases were the image evaluator can assess the margins based on image quality
Time frame: 1.5 years
Will be measured by documenting the number of patients offered study participation and the number choosing to participate in the study
Time frame: one office visit - immediately after imaging procedure
Collect a 3-question questionnaire to document patients experience.
Time frame: To be filled out immediately after finishing Mohs procedure
Will be assessed by results of imaging assessment questionnaire given to surgeon
Time frame: 1.5 years
Will be evaluated by Comparing LC-OCT findings with frozen section histopathological results
Time frame: 1.5 years
will be evaluated by comparing the location of the LC-OCT reported margin positivity to the Mohs map
Contact information is provided by the study sponsor or research team.
Roswell Park Cancer Institute
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07285044
Adenocarcinoma, Adnexal Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT06624475
Basal Cell Carcinoma, Carcinoma
Irvine, California, United States
View Trial DetailsNCT07677124
Basal Cell Carcinoma, Carcinoma
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07241585
Basal Cell Carcinoma, Carcinoma
Cleveland, Ohio, United States
View Trial Details